Professor, Surgery, Ohio State University College of Medicine
General Surgery
Dr. Ginny L. Bumgardner, MD
|
|
Give Review
Ginny Bumgardner practices General Surgery. She attended University of Virginia School of Medicine. She has 1 awards "Fellow (FACS)". Ginny Bumgardner is a published doctor as well. She has 100 publications published. The latest was: Simultaneous pancreas-kidney transplantation at the Ohio State University Medical Center. She accepts all Medicare patients.
Publications
- Critical Role of NKT Cells in Posttransplant Alloantibody Production.
- Alloprimed CD8(+) T Cells Regulate Alloantibody and Eliminate Alloprimed B Cells Through Perforin- and FasL-Dependent Mechanisms.
- Cytotoxic Effector Function of CD4-Independent, CD8+ T Cells Is Mediated by TNF-α/TNFR.
- CD8+ T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production.
- Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.
- Recipient immune repertoire and engraftment site influence the immune pathway effecting acute hepatocellular allograft rejection.
- Steroid-free maintenance immunosuppression with rapamune and low-dose neoral in pancreas transplant recipients.
- Disparate primary and secondary allospecific CD8+ T cell cytolytic effector function in the presence or absence of host CD4+ T cells.
- Reproduction and pregnancy in transplant recipients: current practices.
- Genetic modification of hepatocytes towards hepatocyte transplantation and liver tissue engineering.
- Targeting LFA-1 and cd154 suppresses the in vivo activation and development of cytolytic (cd4-Independent) CD8+ T cells.
- CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
- Evolution of immunosuppression in kidney transplantation: the Ohio State University experience.
- Evidence for tissue-directed immune responses: Analysis of CD4- and CD8-dependent alloimmunity.
- Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after T-tube removal in liver transplantation.
- Magnetic resonance angiography for preoperative evaluation of potential kidney donors.
- Twenty years of renal transplantation at Ohio State University: the results of five eras of immunosuppression.
- Simultaneous pancreas-kidney transplantation at a single center.
- MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host.
- OKT3 (muromonab-CD3) associated hepatitis in a kidney transplant recipient.
- Pancreas after kidney transplantation.
- Inhibition of recall responses through complementary therapies targeting CD8+ T-cell- and alloantibody-dependent allocytotoxicity in sensitized transplant recipients.
- Critical role for CD8 T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade.
- Pharmacokinetics of daclizumab and mycophenolate mofetil with cyclosporine and steroids in renal transplantation.
- Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients.
- Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection.
- Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.
- Hand-assisted laparoscopic versus open nephrectomies in living donors.
- Simultaneous pancreas-kidney transplantation: overview of the ohio state experience.
- The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.
- The optimal number of donor biopsy sites to evaluate liver histology for transplantation.
- Comparative in vitro immunogenicity of cultured murine islets and hepatocytes.
- The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes.
- Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.
- A single center experience with basiliximab induction therapy in renal transplantation.
- A randomized prospective trial of OKT3 induction in the current immunosuppression era.
- Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation.
- Daclizumab (humanized anti-IL2Ralpha mAb) prophylaxis for prevention of acute rejection in renal transplant recipients with delayed graft function.
- Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.
- Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
- Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
- Pulmonary Rhizopus infection in a diabetic renal transplant recipient.
- Obese living kidney donors: short-term results and possible implications.
- Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
- Transplantation and cytokines.
- Pathologic classification of chronic allograft nephropathy: pathogenic and prognostic implications.
- Increased incidence of gastrointestinal surgical complications in renal transplant recipients with polycystic kidney Disease.
- Simultaneous pancreas-kidney transplantation at the Ohio State University Medical Center.
- Costimulation pathways in host immune responses to allogeneic hepatocytes.
- Acute rejection following renal transplantation. Evidence that severity is the best predictor of subsequent graft survival time.
- Efficacy of anti-intercellular adhesion molecule-1 immunotherapy on immune responses to allogeneic hepatocytes in mice.
- Clinical implications of the diagnosis of renal allograft infarction by percutaneous biopsy.
- Effect of tumor necrosis factor alpha and intercellular adhesion molecule-1 expression on immunogenicity of murine liver cells in mice.
- Single-center long-term results of renal transplantation for IgA nephropathy.
- Prophylactic cholecystectomy is not indicated following renal transplantation.
- Simultaneous pancreas/kidney transplantation: comparison of mycophenolate mofetil versus azathioprine.
- Outcome of 300 consecutive pancreas-kidney transplants.
- Impact of intra-Abdominal fluid collections following simultaneous pancreas-kidney transplantation on graft and patient loss.
- Patient survival after renal transplantation: I. The impact of dialysis pre-transplant.
- Function and survival of renal allografts from the same donor transplanted into kidney-only or kidney-pancreas recipients.
- A functional model of hepatocyte transplantation for in vivo immunologic studies.
- In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.
- The kidney/pancreas transplant: an alternative for type I diabetics.
- Clinical and economic impact of flow cytometry crossmatching in primary cadaveric kidney and simultaneous pancreas-kidney transplant recipients.
- Impact of acute rejection and early allograft function on renal allograft survival.
- In vivo immune response to allogeneic hepatocytes.
- The laparoscopic management of post-transplant lymphocele. A critical review.
- Relationships between Arterial hypertension and renal allograft survival in African-American patients.
- Factors related to the donor organ are major determinants of renal allograft function and survival.
- The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients.
- Obesity as a risk factor after combined pancreas/kidney transplantation.
- Impact of serum lipids on long-term graft and patient survival after renal transplantation.
- Decreased graft survival rate in obese pancreas/kidney recipients.
- Risk factors of long-term survivals in combined kidney/pancreas transplantation: a multivariate Analysis of 259 recipients.
- Racial differences in renal allograft survival: the role of systemic hypertension.
- New immunosuppressive agents.
- Newer cephalosporins: lessons to be learned from clinical trials in intraAbdominal infections.
- [Comparison of the results of liver transplantation in children and adults].
- Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus.
- Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
- Prospects for hepatocyte transplantation.
- Long-term outcome of renal transplantation in patients with systemic lupus erythematosus.
- Modulation of MHC class I antigen decreases pancreatic islet immunogenicity.
- Responder T-cell subsets and antigenic stimulus in mixed lymphocyte-hepatocyte culture.
- Role of macrophages in the immune response to hepatocytes.
- Lack of class II antigen expression on hepatocytes profoundly affects CTL development in vitro and in vivo.
- The role of antigen presenting cells in secondary mixed lymphocyte hepatocyte cultures.
- Memory T cells generated in vitro to class I+, II- hepatocytes.
- Comparison of in vivo and in vitro immune response to purified hepatocytes.
- Immunogenicity of class I+, class II- hepatocytes.
- Indirect antigen presentation of hepatocyte (HC) MHC class I antigen in HC-sponge matrix allografts.
- Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-gener...
- Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T...
- Pretransplant sensitization with major histocompatibility complex class I+ class II- hepatocytes leads to accelerated skin graft rejection.
- L3T4+,LyT2- and LyT2+,L3T4- T cells participate in the generation of allospecific cytotoxicity in response to MHC class I+ hepatocytes.
- In vitro immunosuppressive effects of murine hepatocyte cytosol.
- Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes.
- Activation and maturation of alloreactive CD4-independent, CD8 cytolytic T cells.
- Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts.
Schools
University Va School Med
University Of Minnesota
Procedures Preformed
- Anoscopy With Removal of Anal Tumor
- Appendectomy, Open
- Arteriovenous Shunt Creation
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- Appendicitis
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
University of Minnesota at Fairview -
University of Virginia School of Medicine
Hospital
-
Ohio State University Wexner Medical Center -
Nationwide Children's Hospital
Drug Facts
| NPI NUMBER | 1871544189 | |
| NPPES Provider LastName | BUMGARDNER | |
| NPPES Provider FirstName | GINNY | |
| NPPES Provider ZIPCode | 432121472 | |
| NPPES Provider State | OH | |
| Specialty Description | General Surgery | |
| Total Claim Count | 1147.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871544189 |
| Last Name Of The Provider | BUMGARDNER |
| First Name Of The Provider | GINNY |
| View All |
Similar Doctors
|
Dr. Alan E. Harzman, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kristine D. Slam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martha M. Reigel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard E. Schlanger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brenda J. Sickle-Santanello, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Folasade Imeokparia, MD |
|
|
Dr. Eliza W. Beal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marshall C. Spalding, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajan Thakkar, MD
This Doctor is OpenDoctor Recommended.
|